AARDEX Group S.A.
Primary tabs
About your organization / profile
AI-Powered SaaS Platform Revolutionizing Clinical Trials Through Better Drug Exposure
AARDEX Group is a leading digital health company revolutionizing clinical trials with its AI-powered SaaS platform. Our solution ensures real-time, accurate medication adherence monitoring, optimizes dosing, enhances drug exposure, and reduces dropout rates. Integrated with smart packaging suppliers, top clinical trial software platforms, and trusted by major pharma, biotech companies, CROs, and CMOs, AARDEX accelerates trial success. With strong global growth potential, investing in AARDEX supports the future of clinical trials, drives innovation, and unlocks significant returns.
Mature product: over 900 peer-reviewed publications, 1 million monitored patients | Half of the top 20 pharma companies onboarded | 2 to 3 million € annual revenues| Team of 25 | 70% of business in North America | Next steps include reinforcing the management team and marketing activities | Fundraising 4 million euros| Market is in its first major growth phase, less than 2% of the market currently converted to digital | Regulatory bodies pave the way over the last 5 years.
Network (0)
There are no organizations in the network.
Recent activities
AARDEX Group S.A. is now a member of the EIC ACCESS+ community.
AARDEX Group S.A. has been awarded the Seal of Excellence label.
AARDEX Group S.A. has updated its fundraising.
AARDEX Group S.A. has updated its fundraising.
AARDEX Group S.A. has been awarded the ePitches EuroQuity label.
AARDEX Group S.A. has updated its fundraising.
AARDEX Group S.A. has updated its fundraising.
AARDEX Group S.A. has published fundraising documents.
David DALLA VECCHIA has joined AARDEX Group S.A..